Physician profile

Dwight Reynolds

Cardiovascular Disease · Oklahoma City, OK

NPI 1457320285

$47,464.06

in general payments reported to CMS, 2019-2025

9 companies · $111 in 2025

The $111 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General and research payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$2,627.00
Travel and Lodging$738.20
Food and Beverage$726.92
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$375.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $28,393.17 2021-2025 Micra, Cobalt Dr Mri Surescan, Selectsecure
Medtronic Vascular, INC. $17,330.48 2019-2020
Philips North America LLC $1,531.98 2019-2022
Boston Scientific Corporation $92.94 2023-2024 Avvigo Guidance System
Irhythm Technologies, INC. $37.52 2023 Zio Xt Patch
Ethicon US, LLC $26.30 2024 Dermabond Prineo, Ethicon, Stratafix
Kestra Medical Technology Services, INC. $19.10 2023 Assure Wcd
Cashflow Solutions, LLC $16.46 2023 Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt
Teleflex LLC $16.11 2023 Guideliner

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$7,406.25 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Dwight Reynolds

$47,464.06

in general payments reported 2019-2025

Years
2019-2025
Top company
Medtronic, INC.
Context
The $111 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/247691/dwight-reynolds

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.